The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ISHARES TR | CORE S&P US VLU | 464287663 | 92,621 | 1,706,039 | SH | SOLE | 1,706,039 | 0 | 0 | ||
| ISHARES TR | IBOXX HI YD ETF | 464288513 | 26,376 | 314,373 | SH | SOLE | 314,373 | 0 | 0 | ||
| ISHARES TR | MSCI ACWI ETF | 464288257 | 81,930 | 1,025,149 | SH | SOLE | 1,025,149 | 0 | 0 | ||
| ISHARES TR | US TREAS BD ETF | 46429B267 | 13,900 | 497,312 | SH | SOLE | 497,312 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 1,275 | 34,776 | SH | SOLE | 34,776 | 0 | 0 | ||